<DOC>
	<DOCNO>NCT01726517</DOCNO>
	<brief_summary>This study evaluate safety , tolerability , antiviral efficacy ledipasvir/sofosbuvir ( LDV/SOF ) fixed-dose combination ( FDC ) without ribavirin ( RBV ) , administer 8 12 week treatment participant chronic genotype 1 hepatitis C virus ( HCV ) infection treatment-naive , 12 week participants previously receive regimen contain protease inhibitor treatment HCV .</brief_summary>
	<brief_title>Safety Efficacy LDV/SOF Fixed-Dose Combination ( FDC ) ± Ribavirin HCV Genotype 1 Subjects</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Sofosbuvir</mesh_term>
	<mesh_term>Protease Inhibitors</mesh_term>
	<criteria>Age ≥ 18 year , chronic genotype 1 HCV infection HCV RNA equal great 10,000 IU/mL screen Cirrhosis determination ; liver biopsy may require Screening laboratory value within define threshold Use two effective contraception method female childbearing potential sexually active male Pregnant nursing female male pregnant female partner Current prior history clinical hepatic decompensation Hepatocellular carcinoma ( HCC ) malignancy ( exception certain resolve skin cancer ) Chronic use systemic immunosuppressive agent History clinically significant illness medical disorder may interfere subject treatment , assessment compliance protocol</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>HCV genotype 1 ( GT-1 )</keyword>
	<keyword>HCV</keyword>
	<keyword>Sustained Virologic Response</keyword>
	<keyword>Direct Acting Antiviral</keyword>
	<keyword>Combination Therapy</keyword>
	<keyword>GS-7977</keyword>
	<keyword>GS-5885</keyword>
	<keyword>Ribavirin</keyword>
	<keyword>Open Label</keyword>
	<keyword>Sofosbuvir</keyword>
	<keyword>Treatment-Naïve</keyword>
	<keyword>Protease Inhibitors</keyword>
	<keyword>PI</keyword>
</DOC>